280T/H Floor Standing Immunoassay Analyzer CLIA 15min For First Result Fully Automated Used In Hospital CLIA

280T/H Floor-standing Immunoassay Analyzer 15min for First Result Fully Automated Used in Hospital CLIA

Features:

1. Advanced detection principle
The magnetic particle separation chemiluminescence method adopts the current two mainstream immunoassay cutting-edge technologies in the world-magnetic particle carrier technology and chemiluminescence detection technology, which broadens the linear range of detection, improves detection sensitivity and analysis speed, and enables the system to fully meet clinical needs. Requirements for test results.

2. Strong detection throughput
Detection speed: 280T/H.
One-step and two-step on-machine testing at the same time.
The first result can be detected in as fast as 15 minutes, realizing the fastest detection.

3. Stable detection system
Reliable traceability system, traceability to international level professional data processing, intelligent management of calibration quality control with various calibration curve fitting methods, independent judgment of effectiveness.

4. Unique FITC/anti-FITC bridge technology
The superparamagnetic particles are used as the solid phase of the reaction, so that the reaction is more and sufficient, and it is easy to separate the alkaline phosphatase as the labeled enzyme. Compared with HRP, the background value is lower and the sensitivity is higher. It has advanced small molecule labeling technology to enhance the detection accuracy of small molecules.

5. Innovative AP-APLS chemiluminescence technology
High detection sensitivity, wide linear range, single-component substrate, strong stability, easy to use
Novel APLS luminescent substrate. The reaction plateau is reached quickly within 20s, the signal is continuously stable, easy to detect, avoid direct labeling of luminescent substances, not interfered by oxidants, and the signal is more stable.

Zecen Biotech CO., LTD., founded in 2011, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents. Zecen focus on the Chemiluminescent immunoassay (CLIA) field. With all products CE marked, our market presence currently spreads from across China to other countries including India, Switzerland, Russia etc., Zecen is expanding its footprint to become a global brand.

Zecen is the only enterprise with independent intellectual property rights in the entire chemiluminescence industry chain in China, including reagent, instrument, magnetic microbead, and reagent raw material. Our current products include more than 100 assays, from thyroid, inflammation, diabetes, tumer markers, immune disorders, hormones to cardiac markers. Our ever-expanding test menu helps our customers and collaborators keep up with the demands of healthcare sector. Zecen is striving for innovation and perfection to deliver the best products to the customers.

As a manufacturer, Zecen provide the OEM, ODM and other customized service of all products. We have the core R&D centers and innovative ability to lay a solid foundation for developing the broadest range of CLIA analyzers and test menu. High-quality sales and after-sales links provide the more intimate service. The patent and CE certification give us the confident sending all over the world, and more than 50 companys in the requiement of customized and have a long term coorperation with Zecen.